Sign in to Administration. The default account is administrator with blank password.
Home News Latest News HPRA Drug Safety Newsletter Edition 90

HPRA Drug Safety Newsletter Edition 90

Home News Latest News HPRA Drug Safety Newsletter Edition 90
November 05, 2018

​The 90th edition of the HPRA drug safety newsletter. 

The 90th edition of the HPRA drug safety newsletter includes information on the following medicines:

  • Rivaroxaban (Xarelto) – Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement in a prematurely stopped clinical trial.
  • Insulin-containing products -0 Risks of medication errors associated with extraction of insulin from pre-filled pens and cartridges for reusable pens.
  • Hydrochlorothiazide (HCTZ) – Risk of non-melanoma skin cancer (NMSC)
  • Dolutegravir – Neural tube defects reported in infants.

Subscribe to our eZine

Receive our monthly newsletter with news and other content relevant to the Irish nursing and midwifery professions.